Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
Fosamax
Generic name / active ingredient
alendronate
Dosage-form class
Dosage form and presentation as documented in the linked primary label
Route
Oral
Record reviewed
2026-08-23

Copy from the pack in hand

Source-linked reading points

  • Check FOSAMAX, alendronate sodium, oral-tablet form, 70 mg per tablet, NDC 78206-135-01, the four-tablet unit-of-use blister pack and target market together. 70 mg and “four tablets” are identity fields for this official label card, not a web answer to anyone's tablet count, frequency or course.
  • The current label also mentions oral solution, but this dossier does not establish an exact package card for it. A shared brand or generic name does not make tablets, oral solution, other strengths or another-market products self-convertible, substitutable or combinable by tablet count, millilitres or experience.
  • This U.S. label has product-specific instructions about swallowing, water, spacing from food/other medicines and remaining upright. With swallowing difficulty, inability to follow those positioning instructions, or multiple medicines, ask a pharmacist or prescriber before self-switching, splitting or changing timing from a webpage.
  • With swallowing or chest discomfort, significant gastrointestinal symptoms, a dental/procedure plan or another new health issue, bring the actual pack and complete medicine list to a professional; this page does not decide whether to continue, pause or change.

Reviewed presentation examples — compare every field

  • Alendronate sodium 70 mg per tablet; unit-of-use blister pack of 4NDC 78206-135-01

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-08-23
Source record
2 clickable primary-source entry points are listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image